Bolei Cai
Impact in
- Biomaterials top 5%
- Electrospun Nanofibers in Biomedical Applications
- Nanoparticle-Based Drug Delivery
- Cancer Research top 10%
- MicroRNA in disease regulation
Papers in
-
- Extracellular vesicles in disease 5
- RNA Interference and Gene Delivery 4
- Surgery 11
- Co-authors
- Dan Lin (3 shared papers)Shiyu Liu (7 shared papers)Xin Chen (9 shared papers)Ronghua Jin (9 shared papers)Steve GF Shen (2 shared papers)Long Chen (1 shared paper)Hanjiang Zhao (1 shared paper)Anqi Liu (1 shared paper)
- Journals
- Biomaterials (3 papers)ACS Biomaterials Science & Engineering (3 papers)Journal of Cranio-Maxillofacial Surgery (2 papers)Advanced Functional Materials (2 papers)PLoS ONE (2 papers)
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Bolei Cai
43 papers receiving 1.3k citations
Bolei Cai's Hit Papers
Peers
Comparison fields: 5 of 98
- Biomaterials 275
- Cancer Research 260
- Biomedical Engineering 413
- Urology 48
- Molecular Biology 529
Countries citing papers authored by Bolei Cai
This map shows the geographic impact of Bolei Cai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bolei Cai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bolei Cai more than expected).
Fields of papers citing papers by Bolei Cai
This network shows the impact of papers produced by Bolei Cai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bolei Cai. The network helps show where Bolei Cai may publish in the future.
Co-authors
The 25 scholars most cited alongside Bolei Cai, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 44 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Injectable hydrogel with MSNs/microRNA-21-5p delivery enables both immunomodification and enhanced angiogenesis for myocardial infarction therapy in pigs Hit paper breakdown → | 2021 | 211 |
| 2 | 2021 | 172 | |
| 3 | 2021 | 141 | |
| 4 | 2017 | 112 | |
| 5 | 2020 | 90 | |
| 6 | 2019 | 78 | |
| 7 | 2010 | 43 | |
| 8 | 2019 | 39 | |
| 9 | 2011 | 38 | |
| 10 | 2019 | 36 | |
| 11 | 2018 | 27 | |
| 12 | 2022 | 26 | |
| 13 | 2020 | 23 | |
| 14 | 2025 | 22 | |
| 15 | 2022 | 18 | |
| 16 | 2020 | 16 | |
| 17 | 2016 | 16 | |
| 18 | 2020 | 16 | |
| 19 | 2011 | 15 | |
| 20 | 2024 | 14 |
About Bolei Cai
Bolei Cai is a scholar working on Molecular Biology, Surgery, Biomaterials, Biomedical Engineering and Cancer Research, having authored 44 papers that have together received 1.3k indexed citations. Recurring topics across this work include Nanoplatforms for cancer theranostics (9 papers), Nanoparticle-Based Drug Delivery (6 papers), Cancer, Hypoxia, and Metabolism (6 papers), Electrospun Nanofibers in Biomedical Applications (5 papers), Extracellular vesicles in disease (5 papers), Neutrophil, Myeloperoxidase and Oxidative Mechanisms (4 papers), RNA Interference and Gene Delivery (4 papers) and Osteoarthritis Treatment and Mechanisms (3 papers). The work is most often cited by research in Biomaterials (275 citations), Cancer Research (260 citations), Biomedical Engineering (413 citations), Urology (48 citations) and Molecular Biology (529 citations). Bolei Cai has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Dan Lin, Shiyu Liu, Xin Chen, Ronghua Jin, Steve GF Shen, Long Chen, Hanjiang Zhao, Anqi Liu, Kaili Lin and Jirong Xie. Their work appears in journals such as Biomaterials, ACS Biomaterials Science & Engineering, Journal of Cranio-Maxillofacial Surgery, Advanced Functional Materials and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.